Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health care on the Hill

This article was originally published in The Tan Sheet

Executive Summary

Members of Congress are pushing for changes to the health care system through various efforts. Ten senators, including Ron Wyden, D-Ore., and Trent Lott, R-Mo., sent a letter to President Bush Feb. 13 urging him to "fix the American health care system" by considering legislation that would ensure all Americans have affordable health care coverage and bills that would create a "culture of wellness" through prevention strategies. Wyden recently introduced the "Healthy Americans Act" (S 334), which would provide affordable, guaranteed private health coverage for every American "regardless of where they work or live." The bill was referred to the Senate Committee on Finance Jan. 18. Separately, Sen. Jeff Bingaman, D-N.M., and Sen. George V. Voinovich, R-Ohio, introduced the "Health Partnership Act" (S 325) Jan. 17, which seeks to improve the quality and efficiency in the health care system as well as expand coverage and access at the state level...

You may also be interested in...

Herbalife 'Just Getting Started' On Growth Following Flat 2019 At $4.9bn Net Sales

"We're a growth company, well-positioned in a global trend of nutrition that the world hasn't seen before," says co-president John Agwunobi. But the direct seller's record volume increase in 2019 didn’t translate to revenue growth as China, Mexico and Central and South America pulled down results.

US FDA Tech Modernization Plan’s Costs Uncertain

Agency officials determining needs using existing budgets before requesting more funds and will engage with tech investors for design advice.

ICER’s Biopharma Members: Why They Joined And What They Get

Biopharma’s funding support for the Institute for Clinical and Economic Review has been slightly above that of payers and providers for the past three to four years.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts